July 2017

Earlier this week, the Food and Drug Administration (FDA) held a public hearing entitled “The Hatch-Waxman Amendments: Ensuring a…

Seven states and the District of Columbia currently have regulations that limit or ban industry gifts to physicians, and it seems…

In January 2015, HHS set the target of funneling 50% of Medicare payments through alternative payment models and tying 90% of…

On Thursday, July 13, 2017, United States Attorney General Jeff Sessions and Department of Health and Human Services (HHS)…

Measuring the effectiveness of compliance programs is no easy task since governing agencies have not published a template that…

On Wednesday, July 12, 2017, the United States House of Representatives passed a bill via voice vote to reauthorize the…

The Accreditation Council for Continuing Medical Education (ACCME®) recently released the ACCME Data Report: Growth and Evolution…

At the 14th Annual CBI Pharmaceutical Compliance Congress held in April 2017, almost half the attendees were from small to…

In early June 2017, the Pharmaceutical Research and Manufacturers of America (PhRMA) – in partnership with the American…

Already in 2017, the FDA has approved a number of new drugs, which Regulatory Focus points out as a trend away from the low number…